A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.

We deliver transformative solutions that power real results. See how we can help.

Optimizing Supply Chain
Integrating Pharmacy
Maximizing Value-Based Care

Transforming healthcare is more than our objective, it’s in our DNA. We’re dedicated to ensuring better health is just the beginning.

At every level of leadership, Premier’s experts are driving healthcare forward.

Board of Directors
Speakers Bureau

Premier is more than a GPO. Combining robust analytics with consulting and advocacy, we’re changing the healthcare landscape for the better.  

Collective purchasing power lowers costs across your organization.

Intelligence plus unparalleled analytics equals data-driven solutions.

It’s only impossible until it’s not. Premier and our team of experts are transforming care delivery.

Work with Premier members to lower costs, improve quality and safety and succeed in value-based care.

A voice for better healthcare policy is a voice for you.  

Working closely with our members, we’re developing products and services to solve your most complex challenges.

Lower costs, greater efficiencies and a healthier bottom line.

Proven practices that result in better outcomes.

Intersecting specialty drugs with better management and data-driven best practices.

Controlling your future with integrated care delivery practices.

More savings and ROI is a win-win.

Data diving to deliver insights you can act on.

Supporting healthcare transformation through the generation of real-world evidence.

Our most recent insights, articles and more, all in one place.  

Discover what leading healthcare providers are achieving through Premier membership.

Stay informed with our white papers, webinars and e-books.

Browse our blog for a taste of what’s new and what’s next in healthcare.

Premier’s perspectives have been solicited by nationally renowned publications. Read on.

Read Premier’s latest announcements.

Catch our policy statements and perspectives on the latest in DC.

Compelling stories from the front lines of America’s health systems.

Statement on CMS’ Reversal of the Withdrawal of Guidance on the Unapproved Drugs Initiative

By Blair Childs, Senior Vice President, Public Affairs

The Centers for Medicare & Medicaid Services (CMS) and Food and Drug Administration (FDA) should take this opportunity to closely examine the Unapproved Drugs Initiative (UDI) and make needed improvements to the process to ensure that decades-old drugs are still available to consumers at reasonable prices. Premier hopes that the withdrawal is temporary as the administration seeks appropriate public input to determine a safe path forward to prevent unintended consequences of the program such as price gouging and drug shortages. For example, potassium chloride jumped in price from $40.86 in 2015 to $236.93 in 2016 due to the UDI drug pathway. In addition, it created a sole source situation that placed the drug at great risk for shortage.

As the FDA develops guidance on this topic, Premier recommends options for changing the process. These include providing additional notice to manufacturers being forced to exit the marketplace and to providers to allow them to prepare and avoid disruption to patient care. We also call on FDA to fully utilize real-world data and evidence to demonstrate the safety and efficacy for these drugs that have been used in the provision of patient care for decades. Only then will we have a sustainable and attainable solution that will truly impact drug prices and save patients money for safe and effective drug products.

Login Register Change Registration